Keynote: Recently approved therapies and promising approaches for the future

Hear about drugs that have been approved for metastatic breast cancer over the last 2 years and how they impact each subtype of breast cancer. Learn how these latest approvals compare with previous standard-of-care therapies, what we know, and what we don’t, and hear about the exciting drugs and approaches in the pipeline for the next 3 to 5 years.

Speaker: Nancy U. Lin, MD

To learn more about Thriving Together: 2023 Conference on Metastatic Breast Cancer: https://www.lbbc.org/community/events/metsconf23
Be the first to comment